Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market

Qtis.ai launched its first commercial deployment of an AI-native CTMS, EDC and DMS, positioning the company to target the $7.4B clinical research software market. The news is a positive product milestone, but impact is likely limited to the company rather than the broader sector.

Analysis

Qtis.ai launched its first commercial deployment of an AI-native CTMS, EDC and DMS, positioning the company to target the $7.4B clinical research software market. The news is a positive product milestone, but impact is likely limited to the company rather than the broader sector.